期刊文献+

骨保护蛋白/核因子-κβ受体活化因子/核因子-κβ受体活化因子配体轴与心脏瓣膜病合并持续性心房颤动患者改良迷宫术后心房颤动复发的关系及其作用机制研究

Relationship and Mechanism of Action of OPG/RANK/RANKL Axis with Recurrence of Atrial Fibrillation after Modified Maze Procedure in Patients with Valvular Heart Disease with Persistent Atrial Fibrillation
下载PDF
导出
摘要 背景目前研究表明,心脏瓣膜病合并心房颤动(简称房颤)患者改良迷宫术后短期复发可能与心房结构重构有关,探讨该类患者术后房颤复发的可能机制具有一定的临床意义。目的探讨骨保护蛋白(OPG)/核因子-κβ受体活化因子(RANK)/核因子-κβ受体活化因子配体(RANKL)轴与心脏瓣膜病合并持续性房颤患者改良迷宫术后房颤复发的关系及其作用机制。方法选取2016年7月—2019年6月因心脏瓣膜病合并持续性房颤于宜兴市人民医院和南京鼓楼医院行改良迷宫术后转复为窦性心律(简称窦律)患者64例,根据术后3个月时房颤复发情况分为房颤复发组(AF组)27例和窦律维持组(SR组)37例。比较两组患者术前血清OPG、可溶性RANKL(sRANKL)水平、sRANKL/OPG及左心耳组织中基质金属蛋白酶9(MMP-9)、基质金属蛋白水解酶组织抑制因子1(TIMP-1)水平、MMP-9/TIMP-1,并采用Pearson相关分析探讨患者血清sRANKL/OPG与左心耳组织中MMP-9、TIMP-1水平及MMP-9/TIMP-1的关系。结果AF组患者术前血清sRANKL、OPG水平及左心耳组织中MMP-9水平高于SR组,血清sRANKL/OPG、左心耳组织中MMP-9/TIMP-1大于SR组(P<0.05)。Pearson相关分析结果显示,AF组患者血清sRANKL/OPG与左心耳组织中MMP-9/TIMP-1呈正相关(r=0.757,P<0.001),与左心耳组织中MMP-9(r=0.341)、TIMP-1(r=0.190)水平无相关性(P>0.05);SR组患者血清sRANKL/OPG与左心耳组织中MMP-9(r=0.193)、TIMP-1(r=0.107)水平和MMP-9/TIMP-1(r=0.180)无相关性(P>0.05)。结论OPG/RANK/RANKL轴活性增加可能通过调控MMP/TIMP系统影响心房间质纤维化,促进心房结构重构,从而增加心脏瓣膜病合并持续性房颤患者改良迷宫术后房颤复发风险,不利于窦律维持。 Background Current research shows that,recurrence of atrial fibrillation(AF)after modified maze procedure may be related to atrial structural remodeling in patients with valvular heart disease complicated with persistent AF.It is of clinical significance to explore the possible mechanism of recurrence of AF after operation.Objective To investigate the relationship of OPG/RANK/RANKL axis with recurrence of AF after modified maze procedure in patients with valvular heart disease complicated with persistent AF and the mechanism of action.Methods A total of 64 patients who recovered sinus rhythm after modified maze procedure for valvular heart disease with persistent AF were recruited from Yixing People's Hospital and Nanjing Drum Tower Hospital from July 2016 to June 2019,including 27 cases with AF recurrence(AF group)and 37 cases with maintained sinus rhythm(SR group)within 3 months postoperatively.Serum levels of OPG and sRANKL,and sRANKL/OPG ratio,and MMP-9,TIMP levels,and MMP-9/TIMP-1 ratio in the left atrial appendage were compared between the two groups.The relationships of serum sRANKL/OPG with MMP-9,TIMP-1,and MMP-9/TIMP-1 ratio in the left atrial appendage were analysed by Pearson correlation analysis.Results AF group had significantly higher serum levels of preoperative sRANKL and OPG and MMP-9 in the left atrial appendage,and much greater serum sRANKL/OPG ratio and MMP-9/TIMP-1 ratio in the left atrial appendage than SR group(P<0.05).Pearson correlation analysis results showed that,serum sRANKL/OPG ratio was positively correlated with MMP-9/TIMP-1 ratio in the left atrial appendage(r=0.757,P<0.001),but had no correlation with MMP-9(r=0.341)or TIMP-1(r=0.190)in the left atrial appendage in AF group(P>0.05).Moreover,there was no correlation between serum sRANKL/OPG ratio and MMP-9(r=0.193),TIMP-1(r=0.107)or MMP-9/TIMP-1 ratio in the left atrial appendage(r=0.180)in the left atrial appendage in SR group(P>0.05).Conclusion Increased activity of OPG/RANK/RANKL axis may affect the atrial interstitial fibrosis and aggravate the atrial structural remodeling by regulating MMP/TIMP system,leading to increased risk of recurrence of AF after modified maze procedure in patients with valvular heart disease with persistent AF,which is unfavorable for the maintenance of sinus rhythm.
作者 王健 戴婷 蒋国军 曹海龙 WANG Jian;DAI Ting;JIANG Guojun;CAO Hailong(Department of Cardiothoracic Surgery,Yixing People's Hospital,Yixing 214200,China;Department of Pharmacy,Yixing People's Hospital,Yixing 214200,China;Department of Cardiothoracic Surgery,Nanjing Drum Tower Hospital,Nanjing 210008,China)
出处 《实用心脑肺血管病杂志》 2020年第10期32-36,共5页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金 江苏大学临床医学科技发展基金项目(JLY20180003) 无锡市科技发展医疗卫生指导性计划项目(NZ2019050)。
关键词 心房颤动 纤维化 窦性心律维持 基质金属蛋白酶9 护骨素 Atrial fibrillation Fibrosis Sinus rhythm maintenance MMP-9 Osteoprotegerin
  • 相关文献

参考文献3

二级参考文献12

  • 1朱慧,张薇,郭辰虹,张供,张维东,钟明,杨贵荣,葛志明,张运.心房肌基质金属蛋白酶-9和组织金属蛋白酶抑制因子-1表达改变对房颤心房重构机制的研究[J].中华医学杂志,2005,85(1):45-48. 被引量:30
  • 2柯丹,许春萱,林亚洲,张建成,陈林,林立芳,胡锡衷.心房颤动患者心房纤维化分子基础的临床研究[J].中华心血管病杂志,2005,33(5):459-463. 被引量:25
  • 3韦方,邓云坤,李永念.风湿性心脏病心房颤动患者心房组织基质金属蛋白酶表达的研究[J].中国病理生理杂志,2006,22(7):1437-1439. 被引量:8
  • 4Everett TH 4th, Olgin JE. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm 2007; 4(3 Suppl): S24- S27.
  • 5Boldt A,Wetzel U, Lauschke J. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2005; 90: 400-405.
  • 6Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 2004; 109: 363-368.
  • 7Mansour M, Mandapati R, Berenfeld O, Chen J, Samie FH, Jalife J. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation 2001; 103: 2631-2637.
  • 8Arshad JH, victor L, Paul A. Long-term progression and outcomes with aging in patients with lone atrial fibrillation. Circulation 2007; 19: 3050-3056.
  • 9Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M, Chayama K. Matrix metalloprotrinase-9 contributes to human atrial remodeling during atrial fibrillation. J Am Coil Cardiol 2004; 43: 818-825.
  • 10Wu TJ, Doshi RN, Huang HL, Blanche C, Kass RM, Trento A, Cheng W, Karagueuzian HS, Peter CT, Chen PS. Simultaneous biatrial computerized mapping during permanent atrial fibrillation in patients with organic heart disease. J Cardiovasc Electrophysiol 2002; 13: 571-577.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部